Gilead's Tamiflu approved in Japan

GILD and partner F. Hoffmann-La Roche (SWX:ROCZ) received regulatory approval in Japan for Tamiflu oseltamivir oral neuramindiase inhibitor to treat influenza A and B virus infection in adults. On Mon...